Silvia Bolzonello

1.0k total citations
13 papers, 435 citations indexed

About

Silvia Bolzonello is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Silvia Bolzonello has authored 13 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Silvia Bolzonello's work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Silvia Bolzonello is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Silvia Bolzonello collaborates with scholars based in Italy, Ukraine and United States. Silvia Bolzonello's co-authors include Gianpiero Fasola, Giuseppe Aprile, Caterina Fontanella, Elena Ongaro, Michela Guardascione, Lorenzo Gerratana, Fabio Puglisi, V. Fanotto, Marta Bonotto and Alessandro Marco Minisini and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Silvia Bolzonello

10 papers receiving 430 citations

Peers

Silvia Bolzonello
Silvia Bolzonello
Citations per year, relative to Silvia Bolzonello Silvia Bolzonello (= 1×) peers Caterina Fontanella

Countries citing papers authored by Silvia Bolzonello

Since Specialization
Citations

This map shows the geographic impact of Silvia Bolzonello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Bolzonello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Bolzonello more than expected).

Fields of papers citing papers by Silvia Bolzonello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Bolzonello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Bolzonello. The network helps show where Silvia Bolzonello may publish in the future.

Co-authorship network of co-authors of Silvia Bolzonello

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Bolzonello. A scholar is included among the top collaborators of Silvia Bolzonello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Bolzonello. Silvia Bolzonello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lisanti, C., Silvia Bolzonello, Lucia Da Ros, et al.. (2025). Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report. Current Oncology. 32(11). 606–606.
2.
Mazzeo, Roberta, Jonathan E. Sears, Silvia Bolzonello, et al.. (2024). Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncology. ESMO Open. 9(10). 103700–103700. 12 indexed citations
3.
Brisotto, Giulia, Marcella Montico, Matteo Turetta, et al.. (2023). Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects. Viruses. 15(6). 1276–1276. 2 indexed citations
4.
Lisanti, C., Anna Costantini, Mattia Garutti, et al.. (2023). 458P Metastatic breast cancer: How and how often do we communicate? Results from an Italian national survey. Annals of Oncology. 34. S373–S374.
5.
Pelizzari, Giacomo, Elisa Bertoli, Silvia Buriolla, et al.. (2023). Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase. Melanoma Research. 33(5). 398–405. 1 indexed citations
6.
Giorgi, Carlo Alberto, Stefania Russo, Linda Nicolardi, et al.. (2022). Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. Critical Reviews in Oncology/Hematology. 180. 103848–103848. 6 indexed citations
7.
Bartoletti, Michele, Giacomo Pelizzari, Lorenzo Gerratana, et al.. (2019). Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive (PS) recurrent ovarian cancer (rOC)? A network meta-analysis (NMA).. Journal of Clinical Oncology. 37(15_suppl). 5564–5564. 1 indexed citations
8.
Pelizzari, Giacomo, Lorenzo Gerratana, Debora Basile, et al.. (2019). Role of anthracyclines in neoadjuvant anti-HER2 regimens for HER2+ breast cancer (BC): A network meta-analysis (NMA).. Journal of Clinical Oncology. 37(15_suppl). 577–577.
9.
Gerratana, Lorenzo, V. Fanotto, Marta Bonotto, et al.. (2015). Pattern of metastasis and outcome in patients with breast cancer. Clinical & Experimental Metastasis. 32(2). 125–133. 161 indexed citations
10.
Fontanella, Caterina, Silvia Bolzonello, Bianca Lederer, & Giuseppe Aprile. (2014). Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia. Breast Care. 9(4). 239–245. 42 indexed citations
11.
Gerratana, Lorenzo, V. Fanotto, Marta Bonotto, et al.. (2014). Pattern of metastatic spread and prognosis of breast cancer biologic subtypes.. Journal of Clinical Oncology. 32(15_suppl). e12532–e12532. 7 indexed citations
12.
Fontanella, Caterina, Elena Ongaro, Silvia Bolzonello, et al.. (2014). Clinical advances in the development of novel VEGFR2 inhibitors.. PubMed. 2(12). 123–123. 200 indexed citations
13.
Mea, Vincenzo Della, Giuseppe Aprile, Fabio Puglisi, et al.. (2009). Feasibility Study of a Web Application for Self-Report of Anticancer Treatment Toxicities. Studies in health technology and informatics. 150. 562–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026